Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  52,945 results for ""Insulin Glargine""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use.

  • Authors : Seufert J; Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; Freemantle N

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/therapeutic use ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/administration & dosage

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2988-2992. Date of Electronic Publication: 2024 Apr 29.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Real-world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12-month, prospective observational study.

  • Authors : Malik RA; Research Division, Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Qatar.; Hwu CM

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/administration & dosage

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2811-2819. Date of Electronic Publication: 2024 Apr 18.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Management of diabetic ketoacidosis in children: Does early insulin glargine help improve outcomes?

  • Authors : Ohman-Hanson R; Pediatric Endocrinology, University of Colorado School of Medicine, Anschutz Medical Campus and Children's Hospital Colorado, Aurora, Colorado, USA.; Alonso GT

Subjects: Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/therapeutic use ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/administration & dosage ; Diabetic Ketoacidosis*/Diabetic Ketoacidosis*/Diabetic Ketoacidosis*/drug therapy

  • Source: Journal of diabetes [J Diabetes] 2024 Aug; Vol. 16 (8), pp. e13597.Publisher: Blackwell Publishing Asia Country of Publication: Australia NLM ID: 101504326 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A dose titration protocol for once-daily insulin glargine 300 U/mL for the treatment of diabetes mellitus in dogs.

  • Authors : Tardo AM; Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.; Fleeman LM

Subjects: Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/administration & dosage ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/therapeutic use ; Dog Diseases*/Dog Diseases*/Dog Diseases*/drug therapy

  • Source: Journal of veterinary internal medicine [J Vet Intern Med] 2024 Jul-Aug; Vol. 38 (4), pp. 2120-2128. Date of Electronic Publication: 2024 Jun 03.Publisher: Wiley Periodicals Country of Publication: United States NLM ID: 8708660 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study.

  • Authors : Charleer S; Department of Endocrinology, University Hospitals Leuven-KU Leuven, Leuven, Belgium.; Fieuws S

Subjects: Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/therapeutic use ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/administration & dosage ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Jul; Vol. 26 (7), pp. 488-493. Date of Electronic Publication: 2024 Mar 06.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.

Subjects: Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/therapeutic use ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/adverse effects ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jun; Vol. 26 (6), pp. 2412-2421. Date of Electronic Publication: 2024 Apr 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

An exploratory analysis of the cost-effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model.

  • Authors : Shao H; Hubert Department of Global Health, Emory Rollins School of Public Health, Atlanta, Georgia, USA.; Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/therapeutic use; Adult

  • Source: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2024 May; Vol. 41 (5), pp. e15303. Date of Electronic Publication: 2024 Mar 12.Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study.

  • Authors : Hong EG; Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.; Min KW

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/therapeutic use ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: Advances in therapy [Adv Ther] 2024 May; Vol. 41 (5), pp. 1967-1982. Date of Electronic Publication: 2024 Mar 21.Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Clinical Outcomes With Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Insulin-Naïve and Previously Insulin-Treated Individuals With Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials.

  • Authors : Ahmed M; Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.; Shafiq A

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Drug Administration Schedule*

  • Source: Endocrinology, diabetes & metabolism [Endocrinol Diabetes Metab] 2024 May; Vol. 7 (3), pp. e00480.Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101732442 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Insulin Glargine*/Insulin Glargine*/Insulin Glargine*/therapeutic use

  • Source: Journal of diabetes science and technology [J Diabetes Sci Technol] 2024 May; Vol. 18 (3), pp. 653-659. Date of Electronic Publication: 2023 Jan 29.Publisher: Sage Country of Publication: United States NLM ID: 101306166 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  52,945 results for ""Insulin Glargine""